#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal achalasia Nasopharyngeal cancer Small intestine adenocarcinoma HER2 gene amplification Cardiac amyloidosis Malformation venous HER2 mutant non-small cell lung cancer Chronic hepatitis B Porphyria non-acute Chronic lymphocytic leukaemia recurrent Osteosarcoma metastatic Malignant peritoneal neoplasm Extra-osseous Ewing's sarcoma Oesophageal atresia Myocarditis More trials…

    Learn about Rare Diseases

    Behcet’s syndrome – Trials in Disease Sarcoidosis – Treatment Waldenstrom’s macroglobulinaemia refractory Propionic acidaemia – Treatment Haemophilia B without inhibitors – Treatment Cystic fibrosis lung – Basic Information Shprintzen-Goldberg syndrome – Basic Information Von Willebrand’s disease – Diagnostics Turner’s syndrome – Life with Disease Immunodeficiency congenital – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cefazolin Sodium Budigalimab Ht-29-A Phenylephrine Haloperidol Decanoate Alxn1850 Azelastine Hydrochloride STREPTOCOCCUS VIRIDANS TORASEMIDE Ibuprofen Arginine AMLENETUG Olaptesed Pegol Nifedipine Retifanlimab VISUGROMAB Chlorambucil Tas3351 Fluoxetine Cisplatin Empagliflozin More therapies…

    Learn about Your Condition

    Hypoglycaemia Retinal neovascularisation Postprandial hypoglycaemia Naevus flammeus Optic atrophy Myocarditis Psoriatic arthropathy Chronic disease Nephrotic syndrome Fallopian tube cancer Diabetic retinopathy Bacterial vaginosis Craniopharyngioma Tendon injury Herpes zoster More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Graalum

  • Study on Nivolumab for Preventing Melanoma Recurrence in Patients with Completely Removed Stage IIB/C Melanoma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Nivolumab
    Austria Belgium Czechia Denmark Finland France +9

  • Study of Pembrolizumab, Belzutifan, and Lenvatinib for Patients with Advanced Clear Cell Renal Cell Carcinoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Belzutifan
    • Lenvatinib
    • Quavonlimab
    Croatia Czechia Denmark Finland France Germany +8

  • Study on the Effectiveness of Oral Sodium Bicarbonate and Intravenous Hyoscine Butylbromide for Facilitating Natural Childbirth in Pregnant Women Induced for Labor

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Labour induction
    Investigated Drugs:
    • Hyoscine Butylbromide
    • Sodium Hydrogen Carbonate
    • Sodium Chloride
    Norway

  • Study on Paracetamol and Strong Opioids for Pain Relief in Patients with Metastatic Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cancer pain
    • Metastatic neoplasm
    Investigated Drugs:
    • Paracetamol
    • Placebo
    Norway

  • Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Apixaban
    • Asundexian
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

  • Study on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Tecovirimat
    Belgium France Ireland Italy The Netherlands Norway +2
Previous Page
1 … 5 6 7

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Sodium Chloride Prednisone Tenecteplase Nivolumab Apixaban Asundexian Dexamethasone Pembrolizumab Cisplatin Hydrocortisone Gemcitabine Hydrochloride Empagliflozin Nitrous Oxide Prednisolone Ampicillin Sodium Polatuzumab Vedotin Amoxicillin Trihydrate Rbd4059 Povetacicept Benzathine Benzylpenicillin Oxygen Midazolam Hydrochloride Eltrombopag Riluzole Abiraterone Acetate BENZYLPENICILLIN POTASSIUM Hyoscine Butylbromide Ketamine Entecavir Rituximab Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acute myocardial infarction Alcohol use disorder Amyotrophic lateral sclerosis Aortic valve stenosis Arteriosclerosis Atrial fibrillation Bladder cancer Cancer pain Cardiac failure chronic Cardiovascular disorder Cerebrovascular accident prophylaxis Chronic kidney disease Chronic obstructive pulmonary disease Cold type haemolytic anaemia Deafness neurosensory Depression Diffuse large B-cell lymphoma refractory Hormone-refractory prostate cancer Hypertension IgA nephropathy Immune thrombocytopenia Iron deficiency Ischaemic stroke Labour induction Lung disorder Major depression Malignant melanoma Metabolic dysfunction-associated steatohepatitis Metastatic neoplasm Migraine Monkeypox Non-alcoholic steatohepatitis Non-small cell lung cancer Non-small cell lung cancer metastatic Pancreatic carcinoma Plasma cell myeloma Pneumonia Primary adrenal insufficiency Renal cell carcinoma Retinal artery occlusion Sepsis Substance use disorder Thrombosis prophylaxis Transient ischaemic attack Transitional cell carcinoma metastatic Type 2 diabetes mellitus Type IIa hyperlipidaemia Warm autoimmune haemolytic anaemia

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!